glp 1 drugs for weight loss Understanding GLP-1 pills: A new alternative to injections Popular GLP-1 drugs help many

A recent meta-analysis encompassing 11 observational and case-control studies across various countries revealed no statistically significant disparity in suicidal outcomes between GLP-1 RA users and those utilizing alternative antihyperglycemic medications (relative risk, 0.57

In contrast, therapeutically relevant doses of bupropion occupy 15-25% of DAT and do not alter responses on the tyramine pressor test (a proxy of NET inhibition

The SURPASS-CVOT trial, where dulaglutide at the dose of 1.5 mg/week or at the highest tolerated dose, is the comparator, has a distinctive design from the other trials: the primary endpoint is the time to the first manifestation of any major adverse CV event (MACE), defined as myocardial infarction, stroke or CV death

doi:10.1172/JCI97943

Subsequently, Lamers et al